Global Internet of Medical Things IoMT Market 2025 – 2034

Reports Description

As per the Internet of Medical Things IoMT Market analysis conducted by the CMI Team, the global Internet of Medical Things IoMT Market is expected to record a CAGR of 16.1% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 276.85 Billion. By 2034, the valuation is anticipated to reach USD 1061.49 Billion.

Internet of Medical Things IoMT Market Overview

The Internet of Medical Things (IoMT) describes a connected ecosystem of medical devices, applications, health information systems, and services that are connected over networks. Collectively, IoMT devices can gather health data in real-time and provide insights that help care move faster, be more personalized, and be proactive.

Examples of IoMT devices include wearable devices like fitness trackers and ECG monitors, implantable devices such as sensors, remote patient monitoring, and smart equipment in hospitals. The IoMT provides new possibilities for healthcare by allowing for continuous monitoring away from a healthcare facility and bridging the divide between patients and healthcare providers; this adds value particularly with managing chronic conditions and elderly care.

The future of IoMT is bright as the IoMT market is likely to continue its growth trajectory as wireless connectivity will improve, advancements in artificial intelligence will expand, and there will be an ongoing need for solutions to support and expand remote patient care. Additionally, while IoMT devices clearly provide viable avenues to improve the accuracy of diagnostics, reduce hospitalizations, and reduce the overall healthcare costs.

Support from regulations and providers reinvesting in telehealth, digital solutions, and infrastructure in the wake of the COVID-19 pandemic is also contributing to the growth trajectory of these devices. Challenges in this market include security and privacy concerns, low interoperability, and standardization. Despite these challenges, IoMT will undeniably improve healthcare delivery around the world and is primed to be a central platform for smart health ecosystems.

Internet of Medical Things IoMT Market Key Growth Drivers

The Internet of Medical Things IoMT Market Trends has tremendous growth opportunities due to several reasons:

• Increased Demand for Remote Patient Monitoring: Remote Patient Monitoring (RPM) uses connected medical devices to send health data to providers in real-time – thus allowing continuous care outside of clinical settings, thus benefitting chronic disease management and helping to support elderly care. Additionally, as Artificial Intelligence (AI) matures, the development of AI-enhanced RPM systems continues to be greatly anticipated. There are already AI-driven aspects of RPM, including the recognition of health deterioration early, personalized monitoring using federated learning, and behavior pattern identification through reinforcement learning. As these aspects matured, it offered an increased RPM capacity for health intervention, thereby improving patient outcomes. Thus, with the evolution of healthcare, RPM systems are quickly moving towards demanding and essential future healthcare technologies. It has been noted that RPM systems also reduce hospital readmissions, thus offering a cost-effective solution.

• Advancements in Wireless Technology: Advancements in wireless technology such as 5G networks and low-power communication protocols have dramatically improved the functionality of Internet of Medical Things (IoMT) devices. These advancements offer faster data transmission, lower latency, and improved connectivity that make real-time monitoring and data analysis in the healthcare setting much more competent. Additionally, advancements in micro-computing and compact hardware allow for even greater innovation in the IoMT, enabling system innovations that now support timely diagnostics and remote monitoring of chronic conditions. But these advancements have also expanded the attack surface for security risks. Addressing these issues is necessary in order to protect patients and data integrity. Overall, the advancements in wireless technology are changing the way healthcare is delivered.

• Integration with AI and Big Data: The integration of Artificial Intelligence (AI) and Big Data analytics into Internet of Medical Things systems (IoMT) has disrupted the healthcare sector by enabling the processing of massive health datasets. Thus, it allows for predictive analytics, early detection of diseases, and highly individualized treatment plans. Likewise, the AI-driven RPM systems are now able to detect early signs of patient decline, are able to personalize monitoring through federated learning, and are able to determine a patient’s behaviors based on reinforcement learning. All of this enables years of proactive healthcare management, contributing to significant improvements in patient health. Furthermore, the system still provides a support role for healthcare providers and ultimately contributes to making healthcare better and more efficient.

Internet of Medical Things IoMT Market Key Threats

The Internet of Medical Things IoMT Market has a number of primary threats that will influence its profitability and future development. Some of the threats are:

• Cybersecurity Risks: The Internet of Medical Things (IoMT) devices are becoming more interconnected, which may also make them more susceptible to threats from cybercriminals, such as malware and Distributed Denial of Service (DDoS) attacks. The criminal aspect allows patient data to be compromised and health services to be interrupted. Risk factors arise from the lack/weakness of encryption, poor authentication, or infrequent firmware updates. Emerging technologies (i.e. machine learning, blockchain, and edge computing) are being showcased to enhance centralized cybersecurity protocols. There is a focus on lightweight security and standard protocols in order to protect the privacy of sensitive health information. A key component in ensuring cybersecurity in IoMT is patient safety and confidence. Until effective protections become standard practice, healthcare systems are susceptible to risks. Further development efforts are needed in order to provide a secure, resilient IoMT environment.

• Regulatory Convolutions: The regulatory environment for IoMT devices and solutions is convoluted and differs greatly among regions, causing problems for manufacturers and healthcare systems. New regulations, such as data privacy regulations, regulatory safety of devices, and cybersecurity, are hard to interpret, with some burdensome symptoms as well. Adopting IoMT solutions across the globe is still slow, which is becoming increasingly apparent, but interest is widespread. In newly adopted regulations like the EU Medical Device Regulation (MDR), the Network and Information Systems (NIS) Directive, the General Data Protection Regulation (GDPR), and the proposed EU AI Act make it difficult to see the convoluted nature of frameworks. The overlap and interaction of these regulations make it impossible to safeguard AI-enabled medical devices for safety and cybersecurity. Complications are rife. Harmonized rules and clearer guidance are of utmost need. These efforts will lead to a clearer perception of compliance and smoother standards when deploying IoMT technologies and devices globally.

Internet of Medical Things IoMT Market Opportunities

• Growth in Emerging Markets: Growth in Asia, Latin America, and Africa from emerging markets is promising opportunities for IoMT solutions due to their lack of traditional healthcare infrastructure. IoMT technologies can use those conditions to improve healthcare access and healthcare delivery. While it is not indicated what innovations have been developed by the companies, the movement toward AI-enabled Remote Patient Monitoring, and more modern wireless technologies is promising in how IoMT might help address serious healthcare challenges. Expanding IoMT into these markets will depend on how seriously parties can mitigate concerns about risk, such as cybersecurity risks, regulatory barriers, etc. Resolving these issues will be key to the future of IoMT and actualizing better healthcare outcomes in underserved regions. we will probably see most growth prospects in emerging markets.

• Partnerships with Tech Giants: Healthcare organizations with partnerships with technology giants such as those found in the commercial and technology industries are seen as ways of promoting innovations in IoMT solutions. The companies are able to blend the tech component with health components. As partnerships combine innovations in tech with research and clinical know-how, advancing development of interconnected technology also advances improvements in patient monitoring and care. While I do not have insight into the partnership particulars, the express integration of AI and big data analytics into IoMT operational systems indicates that the health sector and tech sectors are in real relationships. Together, they are optimizing the medical device capacity to enable better patient outcomes and more efficient and responsive healthcare delivery. Working together promotes advances in connected health.

Internet of Medical Things IoMT Market Category Wise Insights

By Product

• Stationary Medical Devices: Stationary medical devices are defined as devices not mobile in a healthcare facility, including hospital monitors, MRI equipment, imaging systems, as well as fixed equipment used for diagnostics and continuous patient monitoring. These devices are essential to ensure accurate and consistent healthcare evaluations. For example, the integration of the Internet of Things (IoT) as well as artificial intelligence (AI) into stationary medical devices has been the subject of significant advancement. One study developed a deep learning architecture (DLA) that could be implemented with a 5G network to produce real-time health monitoring capabilities with a predictive value of 96.5% andd 14.4 ms latency. This type of technology will assist clinicians in detecting numerous problems and subsequently starting their management with improved connectivity and realistic response times, establishing improved support for critical care. These developments mark a significant advancement in the viability of modern hospital functionality.

• Implanted medical devices: Implanted medical devices consist of devices inserted into the body by surgery to treat or monitor chronic conditions such as heart rhythm or diabetes. The most notable implanted medical devices include pacemakers, insulin pumps, and neurostimulators. Many of these implanted medical devices have incorporated the remote monitoring capabilities offered by wireless devices. Allowing healthcare providers to constantly monitor various patient conditions has improved the overall trajectory of patient outcomes while also limiting the need for patients to frequently visit their healthcare provider. In 2025, Medtronic announced a spin-off of its diabetes division to meet the demand for advancements in next-generation insulin delivery systems. Continuously seeking improvements over existing insulin-powered delivery systems, they recently announced the MiniMed 780G. The MiniMed 780G is being developed with the goal of automated insulin dosing while the patient is not actively participating in their treatment decisions. The spin-off of their diabetes division allows Medtronic to uphold their legacy with innovation while improving diabetes care.

• Wearable external medical devices: Wearable external medical devices are non-invasive technologies worn on the body to track vital health metrics such as heart rate, glucose levels, and sleep quality. Common examples include smartwatches, fitness bands, and medical-grade wearables used for continuous monitoring. These devices empower patients with real-time health insights and support proactive healthcare management. A recent advancement includes an FDA-approved ring-like wearable designed to monitor sleep patterns and detect disorders such as sleep apnea. This innovation provides extended, comfortable at-home diagnostics. Compared to traditional sleep studies, it enhances convenience and accuracy. Such developments are transforming preventive and personalized healthcare.

By Application

• Telemedicine: Telemedicine is the application of telecommunications across distances to diagnose and treat patients remotely, enabling healthcare providers to deliver medical initiatives and consultations without requiring patients to visit their practices. This expands care access, especially in geographically isolated or underserved areas and enhances efficiency in the delivery of healthcare services. A notable recent example is the Nagpur Municipal Corporation’s telemedicine program that delivered free consultations with specialists to 1,821 patients through two Urban Primary Health Centres. Supported by Western Coalfields Limited and implemented through the Digiswasthya Foundation, this telemedicine initiative demonstrates the ability of telemedicine to fill healthcare gaps and provide appropriate and timely medical assistance to patients in need.

• Medication: Medication management includes prescribing, dispensing, and monitoring medications to ultimately achieve a therapeutic outcome and minimize risk. Medication management includes educating the patient, monitoring medication adherence, and facilitating communication among various members of the health-care team. Recent developments provide some insight into the increasing application of technology in medication management. One recent example consists of the FDA approving a novel device from Masimo that uses pulse oximetry to identify respiratory depression, one of the common risks with opioids, and that notifies users to mitigate overdose. This product improves medication safety in the case of pain management and part of a larger trend.

• Patient Monitoring: In healthcare, patient monitoring refers to the continuous assessment of vital physiological parameters that can include heart rate, blood pressure, and oxygen saturation, with the goal of recognizing variances from the normal range and delivering medical services if required. The recent focus has been on incorporating technology to enhance remote care. A new IoT-based framework for remote monitoring of cardiovascular patients expands the capacity to address patients’ vitals, including heart rate and ECG, in real-time. This IoT-based can be equipped with an alarm system that informs the healthcare provider quickly and in advance so they can take proactive and reactive approaches to patient care, especially if the individual has chronic cardiovascular conditions or is otherwise at risk.

By End-User

• Healthcare Providers: Healthcare organizations, including hospitals, clinics, and practitioners, deploy IoMT (Internet of Medical Things) technologies with the intent of enhancing patient outcomes, improving clinical workflow and maintaining safety, accuracy of diagnostics. These IoMT technologies offer real-time, data-driven decisions and monitoring and enhance personalized care. Most recently, Teladoc Health acquired Catapult Health, a startup for at-home testing, to expand their virtual care services. The goal was to integrate at-home diagnostics into telehealth, meaning clinicians could see results of diagnostic tests and add them to their virtual consults. This indicates a trend moving towards fully integrated, technology-enabled health solutions with a focus on access to care, efficiency, and patient centred care.

• Patients: Patients are the clear winners of IoMT devices and services by receiving improved access to care, real-time access to health insights and personalized treatment options. IoMT technologies invite individuals to participate in their own health management, potentially from home. For example, the FDA recently approved Dexcom’s G7 Continuous Glucose Monitoring System, that offers a 15-day wear time and automatically delivers glucose readings every five minutes. For diabetes management, this is a huge step forward that not only helps patients make timely health decisions but also minimizes the risk of complications in the future, demonstrating another example of how IoMT helps users on a daily basis.

• Government Authorities: Government officials have a huge responsibility, as they have the burden of regulating, funding, and enabling Integrated IoMT (Internet of Medical Things) to meet population health needs and ensure equitable access to health care. Responsibilities include, but are not limited to, developing policy, regulating safety issues, funding, and/or enabling infrastructural developments that would ensure capability and rich access to digital health solutions. For example, the Government of Telangana announced the expansion of telemedicine services through its Sanjeevani portal, which has already helped more than 2.23 crore people, including those in remote and tribal populations. This showcases the government’s commitment to using technology to close gaps in health service delivery to various populations.

Internet of Medical Things IoMT Market Impact of Latest Tariff Policies

The global Internet of Medical Things (IoMT) market is growing rapidly and will be $419.44 billion by 2030, however recently implemented tariff policies, in particular those from the United States, are influencing this growth. The U.S. has levied a universal 10% baseline tariff, and installed a partial or full tariff on certain regions like the European Union, which are important to the medical device industry, a core industry of IoMT. The tariffs are increasing costs of components and finished products, which affect the availability of IoMT devices worldwide.

In addition to the price increase, the tariffs have interfered with the supply chains of medical devices, many devices have parts compromised of components sourced from different countries. For example, Siemens Healthineers’ cutting edge CT scanner Naeotom Alpha, manufactured in Germany, is disrupted in its business due to the proposed global tariffs, especially U.S. tariffs. The U.S. is the consumer of 40% of its exports, if tariffs are imposed, costs will increase, innovation will decrease, and the procurement process will be prolonged. Tariffs risk undermining business for manufacturers and downstream hospital providers and possibly patients, thus impacting access to advanced medical technologies.

To try to combat these challenges, organizations that are in the IoMT market are considering a variety of strategies to mitigate tariff impacts, including diversifying supply chains, increasing their investment in domestic manufacturing, and seeking tariff exemptions where possible. Unfortunately, each of these options requires significant time and resources; the effectiveness of each option also varies by size of company and scope of presence in the market. The multinational IoMT market is still very young and constantly evolving; companies will rely on transparency and be aware of changes in international trade policy in order to constantly grow and innovate despite the challenges posed by tariff-induced obstacles.

Report Scope

Internet of Medical Things IoMT Market Regional Perspective

The Internet of Medical Things IoMT Market can be divided across different regions such as North America, Europe, Asia-Pacific, and LAMEA. This is a cursory overview of each region:

• North America: The emphasis in the United States in 2024 has been to minimize cybersecurity risks associated with healthcare IoT devices, and the United States Energy and Commerce Committee raised the need to mitigate risks to patients and providers from cyberattacks on health facilities, which could disrupt the continuum of care. The United States Department of Veterans Affairs has included funding in their FY 2025 budget for IT modernization and expansion of digital health technologies to improve the delivery of care for veterans. In Canada, investments from 2023 through the nation’s health plan have resulted in further expansion of digital health services and favored the use of IoMT throughout the country.

• Europe: The United Kingdom has capitalized on stakeholder resources to implement IoMT solutions to advance the digital transformation of its National Health Service; increasing patient care while also enhancing the effectiveness of the health system. Germany’s landmark legislation, the Digital Healthcare Act, which was passed in 2020, supports the referral of digital health applications and IoMT devices. Germany now enables reimbursement for the use of digital health applications and extends their use into clinical practice too. In Spain, telemedicine services are expanding via IoMT engagement, improving remote patient monitoring. Spain’s digital healthcare strategy is targeting the improvement of access and quality care in rural and underserved regions within the care context of increasing healthcare access.

• Asia-Pacific: In 2024, India created new projects for the use of Artificial Intelligence (AI) to work with IoMT device data to improve diagnosis and patient monitoring and increase access to healthcare and reduce inefficiencies. China continues to make huge investments in order to create smart healthcare infrastructures that include IoMT technologies as part of China’s rejuvenation modernization strategy to improve patient outcomes. At the same time, Japan is piloting the use of robots with IoMT devices to enhance healthcare delivery by employing them to assist with patient care and improve hospital efficiency.

• LAMEA: Brazil is developing digital health policies aimed at increasing awareness of IoMT device adoption to improve healthcare delivery and accessibility across the country. Countries in the Middle East and Africa are also integrating healthcare technologies, including IoMT, to improve medical services. Fueled by government policies and growing private investments, these regions are working towards modernizing their healthcare capabilities and disparities while increasing patient care through technologies.

Internet of Medical Things IoMT Market Key Developments

In recent years, the Internet of Medical Things IoMT Market has experienced several crucial changes as the players in the market strive to grow their geographical footprint and improve their product line and profits by using synergies.

• In June 2024, Apple Inc. previewed iOS 18 for the iPhone, making the device more capable, secure, and intelligent. In the latest update to the Health App, the Medical ID feature has been overhauled to streamline access to critical information for first responders during emergencies. The app has also been integrated with enhanced functionality to support individuals during pregnancy, offering personalized insights and suggestions based on changes in both physical and mental health conditions.

• In May 2024, GE HealthCare Technologies Inc. and Tampa General Hospital (TGH), an academic health system, agreed to deploy GE HealthCare Technologies Inc.’s Imaging and Ultrasound technology solutions for the benefit of clinicians and patients in TGH Imaging’s outpatient facilities across the U.S. state of Florida.

• In September 2023, Microsoft Corporation and Mercy, a healthcare system based in the U.S., announced a long-term collaboration to use digital technologies, including generative AI, to improve patient experiences by allowing advanced practice providers, physicians, and nurses to give more time to care for patients. Plans envisage Mercy utilizing Microsoft Corporation’s Azure OpenAI Service to enhance care by enabling more informed health discussions between clinicians and patients through AI-assisted conversations.

These important changes facilitated the companies in widening their portfolios, bolstering their competitiveness, and exploiting the possibilities for growth available in the Internet of Medical Things IoMT Market. This phenomenon is likely to persist since most companies are struggling to outperform their rivals in the market.

Internet of Medical Things IoMT Market Competitive Landscape

The Internet of Medical Things IoMT Market is highly competitive, with a large number of product providers globally. Some of the key players in the market include:

• Boston Scientific Corporation
• General Electric Company (GE Healthcare)
• Johnson & Johnson Services Inc.
• Medtronic
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Cisco
• IBM
• Baxter (Hill-Rom Services Inc.)
• BIOTRONIK
• Others

These firms apply a sequence of strategies to enter the market, including innovations, mergers, and acquisitions, as well as collaboration.

The Internet of Medical Things (IoMT) Market is led by industry giants such as Medtronic, Koninklijke Philips N.V., Johnson & Johnson Services, Inc., Boston Scientific Corporation, and GE Healthcare, who provide advanced connected medical devices and integrated healthcare solutions.

These companies focus on developing innovative remote patient monitoring systems, wearable health devices, and AI-driven diagnostic tools that enhance real-time patient care and improve clinical outcomes. Medtronic, for example, recently launched a cloud-based remote monitoring platform that seamlessly integrates with electronic health records, enabling clinicians to track patient data continuously and intervene proactively.

Tech companies like Microsoft Azure, AWS, and Google Cloud are rapidly expanding their healthcare cloud services to support the increasing demand for scalable, secure IoMT data management and analytics. In 2023, Microsoft Azure introduced a dedicated IoMT framework designed to facilitate faster device integration, streamline compliance with healthcare regulations, and ensure robust data privacy.

AWS also enhanced its IoT for Healthcare offering by enabling faster deployment of connected medical devices through automated configuration, helping healthcare providers manage large-scale IoMT ecosystems more efficiently. These cloud innovations are critical for supporting the vast volumes of sensitive data generated by IoMT devices while maintaining high security and compliance standards.

Local partnerships and collaborations are accelerating IoMT adoption across diverse regions. In 2024, Koninklijke Philips partnered with the UK’s National Health Service (NHS) to implement IoMT-powered remote patient monitoring programs in multiple hospitals, improving care for chronic disease patients and reducing hospital readmissions.

Similarly, GE Healthcare teamed up with India’s Apollo Hospitals in 2025 to deploy smart intensive care units equipped with IoMT sensors for real-time patient monitoring and enhanced clinical decision-making. These strategic alliances, combining global expertise with regional healthcare needs, are driving the widespread deployment of IoMT technologies, transforming healthcare delivery models, and making connected care solutions accessible to a broader population worldwide.

The Internet of Medical Things IoMT Market is segmented as follows:

By Product

• Stationary Medical Devices
• Implanted Medical Devices
• Wearable External Medical Devices

By Application

• Telemedicine
• Medication Management
• Patient Monitoring

By End-user

• Healthcare Providers
• Patients
• Government Authorities

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America